共 54 条
[1]
Bachanova V., Connors J.M., Hodgkin lymphoma in the elderly, pregnant, and HIV-infected, Semin. Hematol, 53, pp. 203-208, (2016)
[2]
Greenberg K.I., Perazella M.A., Atta M.G., HIV and HCV medications in end-stage renal disease, Semin. Dial, 28, pp. 397-403, (2015)
[3]
Scientific Coordination Committee Marcotullio S., Andreoni M., Antinori A., d'Arminio Monforte A., Di Perri G., Galli M., Ippolito G., Perno C.F., Rizzardini G., Lazzarin A., Cinque P., Fares G., Foglia E., Gervasoni C., Murri R., Nozza S., Rusconi S., The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection, New Microbiol, 35, pp. 259-277, (2012)
[4]
Pitt J., Myer L., Wood R., Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme, J. Int. AIDS Soc, 12, (2009)
[5]
Nagiah S., Phulukdaree A., Chuturgoon A., Mitochondrial and oxidative stress response in HepG2 cells following acute and prolonged exposure to antiretroviral drugs, J. Cell. Biochem, 116, pp. 1939-1946, (2015)
[6]
Casado J., Mena A., Banon S., Castro A., Quereda C., Moreno A., Pedreira J., Moreno S., Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis, HIV Med, 17, pp. 62-67, (2016)
[7]
da Rocha I.M., Gasparotto A.S., Lazzaretti R.K., Notti R.K., Sprinz E., Mattevi V.S., Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort, Pharmacogenet. Genomics, 25, pp. 541-547, (2015)
[8]
Dorsey J.L., Mangus L.M., Hauer P., Ebenezer G.J., Queen S.E., Laast V.A., Adams R.J., Mankowski J.L., Persistent peripheral nervous system damage in simian immunodeficiency virus-infected macaques receiving antiretroviral therapy, J. Neuropathol. Exp. Neurol, 74, pp. 1053-1060, (2015)
[9]
Azu O.O., Naidu E.C., Naidu J.S., Masia T., Nzemande N.F., Chuturgoon A., Singh S., Testicular histomorphologic and stereological alterations following short-term treatment with highly active antiretroviral drugs (HAART) in an experimental animal model, Andrology, 2, pp. 772-779, (2014)
[10]
Adaramoye O.A., Akanni O.O., Adewumi O.M., Owumi S.E., Lopinavir/ritonavir, an antiretroviral drug, lowers sperm quality and induces testicular oxidative damage in rats, Tokai J. Exp. Clin. Med, 40, pp. 51-57, (2015)